Gossamer Bio, Inc. (GOSS) Form 10-K Annual Reports
Gossamer Bio, Inc. (GOSS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GOSS
CIK: 1728117
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerKelly Hayes
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-08 | — | SCHEDULE 13D/A Filing | 0001104659-26-114792 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-28 | — | SCHEDULE 13D/A Filing | 0001104659-26-111463 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001728117-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063624 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063619 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063616 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063610 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063606 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063601 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001628280-26-063593 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001728117-26-000104 | View SEC Doc Filr Page |
| 3 | 2026-09-22 | 2026-09-16 | FORM 3 | 0001628280-26-063097 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-16 | 2026-10-27 | DEF 14A | 0001728117-26-000102 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001728117-26-000101 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0001728117-26-000094 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001728117-26-000091 | View SEC Doc Filr Page |
| D | 2026-09-04 | — | D Filing | 0001728117-26-000088 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-03 | 2026-09-03 | PRE 14A | 0001728117-26-000086 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001728117-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001553179-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001857256-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0002003059-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001740847-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001352620-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-24 | 8-K | 0001728117-26-000079 | View SEC Doc Filr Page |